Blepharitis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Blepharitis is one of the most common ocular disorders encountered in clinical practice. Although blepharitis is one of the most common ocular disorders, epidemiological information on its incidence or prevalence within defined populations is lacking. | Blepharitis is one of the most common ocular disorders encountered in clinical practice. Although blepharitis is one of the most common ocular disorders, epidemiological information on its incidence or prevalence within defined populations is lacking. | ||
Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and [[meibomian gland | Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and [[meibomian gland|meibomian gland dysfunction (MGD)]].<ref name="pmid19277245">{{cite journal| author=Macsai MS| title=The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). | journal=Trans Am Ophthalmol Soc | year= 2008 | volume= 106 | issue= | pages= 336-56 | pmid=19277245 | doi= | pmc=2646454 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19277245 }} </ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 15:39, 14 July 2016
|
Blepharitis Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Blepharitis epidemiology and demographics On the Web | |
|
American Roentgen Ray Society Images of Blepharitis epidemiology and demographics | |
|
Risk calculators and risk factors for Blepharitis epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Blepharitis is one of the most common ocular disorders encountered in clinical practice. Although blepharitis is one of the most common ocular disorders, epidemiological information on its incidence or prevalence within defined populations is lacking. Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and meibomian gland dysfunction (MGD).[1]
Epidemiology and Demographics
Blepharitis is one of the most common ocular disorders encountered in clinical practice. Up to 20,000 per 100,000 adults over the age of 45 report some discomfort from blepharitis and meibomian gland dysfunction (MGD).[1]
Age
Blepharitis can affect all age groups. Chronic blepharitis commonly affects middle age population. (50 years old). Staphylococcal blepharitis commonly affects younger population (42 years old).[2]
Gender
No predilection towards either gender exists. However, Female are more commonly affected with staphylococcal blepharitis than males.[3]
Race
There is no racial predilection to blepharitis.
Developed Countries
In developed countries/United States, blepharitis affects more than 25 million people. In a survey ophthalmologists and optometrists report that blepharitis is commonly seen in clinical practice ranges a low of 37.000 per 100,00 patients, to a high of 47,000 per 100,000 patients.[4]
References
- ↑ 1.0 1.1 Macsai MS (2008). "The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)". Trans Am Ophthalmol Soc. 106: 336–56. PMC 2646454. PMID 19277245.
- ↑ Dougherty JM, McCulley JP (1984). "Comparative bacteriology of chronic blepharitis". Br J Ophthalmol. 68 (8): 524–8. PMC 1040405. PMID 6743618.
- ↑ American Academy of Ophthalmology/ eyewiki (2016) http://eyewiki.aao.org/EyeWiki%3AGeneral_disclaimer%7C Accessed on July 14, 2016
- ↑ Lemp MA, Nichols KK (2009). "Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment". Ocul Surf. 7 (2 Suppl): S1–S14. PMID 19383269.